Largest Shareholder Edward Smolyansky Calls for 'No Confidence' Vote Against Lifeway Board After Poison Pill Termination
LWAY sits 38% above its 52-week low of $17.31 on light trading volume (0.3× avg).
Summary
Lifeway's largest shareholder, Edward Smolyansky, publicly criticized the board's "reactive governance" after the company terminated its poison pill. Smolyansky is urging shareholders to cast a "vote of no confidence" against incumbent directors at the June 17 Annual Meeting. The poison pill was removed only after proxy advisory firm ISS recommended against the entire board, highlighting significant external pressure. This follows Danone's recent full exit of its 22.61% stake, which Smolyansky notes has fundamentally altered the company's ownership structure. This escalating governance battle could lead to board changes and impact Lifeway's strategic direction. The June 17 Annual Meeting will be a key event to watch.
At the time of this announcement, LWAY was trading at $23.83 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $364.2M. The 52-week trading range was $17.31 to $34.20. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: PR Newswire.